Potential urine NMR Metabolomic signatures for early diagnosis of paediatric tuberculosis
Por:
López-Suárez, A, Comella-del-Barrio, P, Alonso-Moreno, P, Marín, Y, Villa-Valverde, P, Santos-Sebastián, M, Noguera-Julian, A, Gamell, A, Rodríguez-Molino, P, Hurtado-Gallego, J, Blázquez-Gamero, D, Jiménez-Jiménez, AB, Navas, A, del Castillo, E, Llorente, M, Sainz, T, Domínguez, J, Izquierdo-García, JL and Santiago-García, B
Publicada:
23 feb 2026
Resumen:
Early diagnosis of tuberculosis (TB) in children is hampered by non-specific symptoms, low bacillary loads, and difficulties in obtaining respiratory samples. We evaluated urinary metabolomics using high-resolution nuclear magnetic resonance (HR-H-1-NMR) spectroscopy as a non-invasive tool to discriminate TB disease, TB infection (TBI), and healthy controls (HC). Urine samples from 101 children enrolled in the Spanish Paediatric TB Network (pTBred) were retrospectively analysed, including 62 TB cases (26 microbiologically confirmed [cTB]), 17 TBI, and 22 HC. Metabolic fingerprints were generated via(1) H-NMR spectroscopy. Group discrimination was assessed using partial least squares discriminant analysis (PLS-DA) with cross-validation. Metabolites were selected using VIP > 2 and p < 0.05. Validated PLS-DA models (TB vs. HC, cTB vs. HC and cTB vs. TBI) achieved >= 70% accuracy (AUC-ROC 0.867-0.971), with sensitivities ranging from 69.1% to 90.0% and specificities from 77.3% to 86.7%. Discrimination was strongest for cTB vs. TBI (AUC-ROC 0.971; sensitivity 90.0%; specificity 86.7%). A set of discriminatory metabolites was identified across validated comparisons. Compared with HC, TB disease was characterized by increased levels of phenylalanine and two unidentified NMR signals, together with reductions in several energy and nitrogen-related metabolites; benzoate and histidine showed borderline differences. In contrast, TBI was associated with higher levels of isoleucine, N-acetylglutamine, glutamine, creatinine and 2-hydroxyvalerate. Urine HR-H-1-NMR metabolomics suggests potential distinct metabolic signatures across TB states. While not yet suitable as a confirmatory test, these preliminary findings show potential as a triage tool to help prioritise children for microbiological testing and may eventually reduce the need for invasive sampling.
Filiaciones:
López-Suárez, A:
Gregorio Maranon Hosp, Paediat Dept, Pediat Infect Dis Unit, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
Univ Complutense Madrid, Madrid, Spain
Gregorio Maranon Res Hlth Inst IiSGM, Madrid, Spain
Comella-del-Barrio, P:
Gregorio Maranon Hosp, Paediat Dept, Pediat Infect Dis Unit, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
Gregorio Maranon Res Hlth Inst IiSGM, Madrid, Spain
Alonso-Moreno, P:
Univ Complutense Madrid, Madrid, Spain
Inst Pluridisciplinar, Dept Chem Pharmaceut Sci, NMR & Imaging Biomed Grp, Madrid, Spain
Marín, Y:
Univ Complutense Madrid, Madrid, Spain
Inst Pluridisciplinar, Dept Chem Pharmaceut Sci, NMR & Imaging Biomed Grp, Madrid, Spain
Villa-Valverde, P:
Univ Complutense Madrid, Madrid, Spain
Inst Pluridisciplinar, Dept Chem Pharmaceut Sci, NMR & Imaging Biomed Grp, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Resp Dis CIBERES, Madrid, Spain
Univ Complutense Madrid, ICTS Bioimagen Complutense, Madrid, Spain
Santos-Sebastián, M:
Gregorio Maranon Hosp, Paediat Dept, Pediat Infect Dis Unit, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
Gregorio Maranon Res Hlth Inst IiSGM, Madrid, Spain
Noguera-Julian, A:
Inst Recerca Pediat St Joan de Deu, Malalties Infeccioses & Resposta Inflamatoria Sist, Serv Infectol, Barcelona 08950, Spain
Univ Barcelona, Dept Cirurgia & Especialitats Medicoquirurg, Fac Med & Ciencies Salut, Barcelona 08036, Spain
Biomed Res Ctr Network Red Epidemiol & Publ Hlth C, Madrid 28029, Spain
Gamell, A:
Inst Recerca Pediat St Joan de Deu, Malalties Infeccioses & Resposta Inflamatoria Sist, Serv Infectol, Barcelona 08950, Spain
Rodríguez-Molino, P:
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
La Paz Hosp, Dept Infect Dis & Trop Paediat, Madrid, Spain
La Paz Res Hlth Inst IdiPAZ, Madrid, Spain
Hurtado-Gallego, J:
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
La Paz Hosp, Dept Infect Dis & Trop Paediat, Madrid, Spain
La Paz Res Hlth Inst IdiPAZ, Madrid, Spain
Blázquez-Gamero, D:
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
Univ Complutense Madrid, Hosp Univ Octubre 12, Hosp Octubre Res Hlth Inst 12 Imas12, Paediat Infect Dis Unit, Madrid, Spain
Jiménez-Jiménez, AB:
Hosp Univ Fdn Jimenez Diaz, Serv Pediat, Infectol Pediat, Madrid, Spain
Navas, A:
Infanta Leonor Univ Hosp, Madrid, Spain
del Castillo, E:
Badajoz Matern & Childrens Hosp, Badajoz, Spain
Llorente, M:
Arganda Hosp, Pediat Serv, Working Grp Resp Infect Spanish Soc Paediat Infect, Madrid, Spain
Sainz, T:
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
La Paz Hosp, Dept Infect Dis & Trop Paediat, Madrid, Spain
Univ Autonoma Madrid, Madrid, Spain
La Paz Res Hlth Inst IdiPAZ, Madrid, Spain
:
Carlos III Hlth Inst, Biomed Res Ctr Network Resp Dis CIBERES, Madrid, Spain
Autonomous Univ Barcelona, Germans Trias I Pujol Res Inst, Barcelona, Spain
Autonomous Univ Barcelona, Genet & Microbiol Dept, Barcelona, Spain
Izquierdo-García, JL:
Univ Complutense Madrid, Madrid, Spain
Inst Pluridisciplinar, Dept Chem Pharmaceut Sci, NMR & Imaging Biomed Grp, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Resp Dis CIBERES, Madrid, Spain
Univ Complutense Madrid, ICTS Bioimagen Complutense, Madrid, Spain
Santiago-García, B:
Gregorio Maranon Hosp, Paediat Dept, Pediat Infect Dis Unit, Madrid, Spain
Carlos III Hlth Inst, Biomed Res Ctr Network Infect Dis CIBERINFEC, Madrid, Spain
Gregorio Maranon Res Hlth Inst IiSGM, Madrid, Spain
Green Submitted, gold
|